Cargando…

Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?

A recently published paper addressed the interesting topic of prevention of erectile dysfunction (ED) with tadalafil, a phosphodiesterase-type 5 inhibitor (PDE5i) in patients undergoing radiation therapy for localized prostate cancer.1 Tadalafil 5 mg or placebo was administered once-daily for 24 wee...

Descripción completa

Detalles Bibliográficos
Autor principal: Incrocci, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215677/
https://www.ncbi.nlm.nih.gov/pubmed/24969064
http://dx.doi.org/10.4103/1008-682X.133324